Cell Injury & Adaptation: Reversible injury, irreversible injury/necrosis, apoptosis vs necroptosis/pyroptosis, autophagy, cellular adaptations (hypertrophy, hyperplasia, atrophy, metaplasia), intracellular accumulations (lipids, proteins, pigments), calcification (dystrophic vs metastatic).
Inflammation & Repair: Acute (vascular/cellular phases, exudates), chronic (macrophages, lymphocytes, granulomas), mediators (amines, eicosanoids, cytokines, complement), wound healing (primary/secondary intention), fibrosis & scarring.
Haemodynamics: Oedema, hyperaemia vs congestion, haemorrhage, thrombosis (Virchow triad), embolism (thrombo-, fat, air, amniotic), infarction (red/white), shock (hypovolaemic, cardiogenic, obstructive, distributive/septic).
Genetic & Environmental: Mendelian & chromosomal disorders, epigenetics, teratogens, nutrition (deficiency/toxicity), environmental pathology (alcohol, tobacco, occupational), ageing & cellular senescence.
Neoplasia: Nomenclature, benign vs malignant, dysplasia/CIS, hallmarks of cancer, oncogenes/tumour suppressors, genomic instability, invasion & metastasis, tumour microenvironment, grading vs staging, paraneoplastic syndromes.
Immunopathology & Amyloidosis: Hypersensitivity I–IV, autoimmunity principles, transplant pathology (rejection/GVHD), amyloid types & organ patterns.
Infectious Disease Pathology: Tissue reaction patterns (suppurative, granulomatous, necrotising, fibrinous), sepsis pathobiology, opportunistic infections.
Systemic Pathology (High-Yield): CVS (atheroma, infarcts), Respiratory (COPD, asthma, interstitial disease, lung cancer), GI–Liver–Pancreas (IBD, cirrhosis, hepatitis, pancreatitis, GI tumours), Renal (GN/NT, AKI/CKD, tumours), Endocrine (thyroid, adrenal), Haematopathology (anaemias, leukaemias/lymphomas, myeloma), CNS (stroke, demyelination, tumours), Skin/Breast/Bone.
Laboratory Pathology: Grossing to diagnosis: H&E, special stains, immunohistochemistry (IHC), cytology, flow cytometry, molecular pathology (PCR/FISH/NGS), quality & safety.

🧪 Cell injury – mechanisms & morphologic correlates

ATP depletion (ischaemia/mitochondrial tox) → pump failure (Na\(^+\)/K\(^+\)), cellular swelling, ↑anaerobic glycolysis (↓pH), ribosomal detachment (↓protein synthesis).
ROS (reperfusion injury, inflammation) damage lipids (peroxidation), proteins, DNA. Antioxidants: SOD, catalase, glutathione peroxidase.
Membrane damage (phospholipase activation, cytoskeletal injury) → ↑Ca\(^{2+}\) influx → enzymatic self-digestion.
Reversible injury: cell swelling, fatty change, blebs, clumped chromatin. Irreversible: membrane rupture, massive Ca\(^{2+}\) influx, mitochondrial amorphous densities, nuclear changes (pyknosis→karyorrhexis→karyolysis).
Apoptosis: intrinsic (BAX/BAK via ↓BCL2; cytochrome c → caspase-9) or extrinsic (Fas/FasL, TNF) → caspase cascade; cell shrinkage, chromatin condensation, apoptotic bodies; no inflammation. Necroptosis: RIPK1/3-MLKL, caspase-independent; Pyroptosis: inflammasome–caspase-1, IL-1β release.

🧬 Adaptations & accumulations

Hypertrophy (pressure load myocardium), Hyperplasia (hormonal endometrium), Atrophy (denervation), Metaplasia (Barrett: squamous→columnar).
Steatosis (alcohol, NAFLD), Hyaline change, Cholesterol (xanthomas/atheroma), Hemosiderin (Prussian blue), Lipofuscin (wear-and-tear), Glycogen (PAS).
Calcification: dystrophic (normal Ca\(^{2+}\), injured tissue; atherosclerosis, damaged valves) vs metastatic (hypercalcaemia; kidney, lung, gastric mucosa).

🔥 Inflammation & repair essentials

Acute: vasodilation (histamine), ↑permeability (endothelial contraction), leukocyte recruitment (selectins→integrins via IL-1/TNF), transmigration (PECAM-1), chemotaxis (C5a, LTB\(_4\), IL-8), phagocytosis (opsonins IgG/C3b).
Mediators: Histamine/serotonin, arachidonic acid (COX→PGs, LOX→LTs), NO, cytokines (IL-1/TNF/IL-6), complement (C3a/C5a), kinins.
Chronic: macrophages (M1 vs M2), lymphocytes, plasma cells; granulomas (epithelioid histiocytes ± giant cells; caseating TB vs non-caseating sarcoid/beryllium/foreign body).
Healing: labile vs stable vs permanent cells; granulation tissue (angiogenesis, fibroblasts, type III collagen → type I), TGF-β-driven fibrosis; contractures & keloid/hypertrophic scars.

🩸 Haemodynamics – from oedema to shock

Transudate (↓oncotic/↑hydrostatic) vs Exudate (↑vascular permeability). Virchow triad: endothelial injury, stasis/turbulence, hypercoagulability.
Thrombi: lines of Zahn (arterial). Emboli: DVT→PE; fat (long bone), air (decompression/central line), amniotic (DIC), septic.
Infarcts: white (solid organs) vs red (dual blood supply/reperfusion); wedge-shaped, ischaemic coagulative necrosis (liquefactive in brain).
Shock: cellular hypoxia → lactic acidosis, multi-organ dysfunction. Septic shock: dysregulated host response (NO-mediated vasodilation, endotheliopathy, DIC).

🧫 Neoplasia – language & logic

Benign (oma) vs Malignant (carcinoma/sarcoma); exceptions: melanoma, lymphoma, hepatoma are malignant.
Dysplasia→CIS→invasion (breach basement membrane). Hallmarks: autonomous growth, resist death, immortality (telomerase), angiogenesis, invasion/metastasis, dysregulated metabolism, evasion of immunity.
Oncogenes (KRAS, MYC), Tumour suppressors (TP53, RB), DNA repair (BRCA, MMR). Carcinogens: chemical (aflatoxin→HCC), physical (UV), microbial (HPV E6/E7, EBV).
Spread: lymphatic (carcinoma), haematogenous (sarcoma; RCC/HCC via veins), seeding (ovarian in peritoneum).
Grading (differentiation/mitoses) vs Staging (TNM: depth/nodes/metastasis) - stage predicts outcome.
Paraneoplastic: ectopic hormones (ACTH, PTHrP), neurologic (anti-Hu), hypercoagulability (Trousseau).

🧵 Amyloidosis & immune pathology

Amyloid: β-pleated misfolded proteins; Congo red apple-green birefringence. AL (light chain; plasma cell), AA (chronic inflammation), Aβ (Alzheimer), Aβ\(_2\)M (dialysis), ATTR (transthyretin, age/hereditary).
Hypersensitivity: I (IgE), II (antibody-mediated), III (immune complex), IV (T-cell) - learn organ examples.

🧫 Laboratory pathology – from slide to signature

H&E baseline; special stains: PAS (glycogen/fungi), ZN (acid-fast), GMS (fungi), Prussian blue (iron), Congo red (amyloid), Masson trichrome (fibrosis), Oil Red O (lipid in frozen).
IHC: cytokeratin (carcinoma), vimentin (mesenchyme), S100/SOX10 (melanocytic), desmin (muscle), CD45 (lymphoid), CD3/CD20 (T/B), CD68 (histiocytes), ER/PR/HER2 (breast), TTF-1/Napsin-A (lung adeno), p40 (squamous), PSA (prostate).
Molecular: FISH (HER2, ALK), PCR/NGS (EGFR, KRAS, BRAF, IDH, NPM1), clonality (IGH/TCR), MMR/MSI for Lynch/predictive immunotherapy.
Flow cytometry: leukaemia/lymphoma immunophenotype, light-chain restriction.

📏 Core Tables – Patterns, Stains & Differentials

Topic	Key distinctions	Exam pearls
Necrosis types	Coagulative (ischaemia solid organs); Liquefactive (brain, abscess); Caseous (TB); Fat (saponification in pancreatitis/trauma); Fibrinoid (immune vasculitis)	Brain infarct → liquefactive; TB granuloma → caseous centre
Exudate vs transudate	Protein-rich, cellular, high LDH vs protein-poor, low cells	Pleural Light’s criteria for exudate (>0.5 protein ratio or >0.6 LDH ratio or LDH > 2/3 ULN)
Thrombosis risks	Endothelial injury; stasis/turbulence; hypercoagulability	Factor V Leiden (APC resistance); malignancy (Trousseau)
Amyloid types	AL (plasma cell), AA (inflammatory), ATTR (transthyretin), Aβ (brain)	Restrictive cardiomyopathy, nephrotic syndrome, macroglossia
Paraneoplastic	PTHrP (squamous lung), ACTH (small cell), SIADH (small cell), hypercoagulability (adenocarcinomas)	Neurologic (anti-Hu in small cell), dermatomyositis with malignancy
Nephrotic vs nephritic	Nephrotic: heavy proteinuria, oedema, hyperlipidaemia; Nephritic: haematuria, mild proteinuria, HTN	Minimal change (children; steroids), FSGS (HIV/heroin), Membranous (PLA2R, malignancy), Post-strep GN (hump), RPGN (crescent; linear anti-GBM vs granular immune complex vs pauci-immune ANCA)
Anaemia patterns	Microcytic (iron deficiency, thalassaemia, chronic disease), Normocytic (acute blood loss, haemolysis, CKD), Macrocytic (B12/folate, liver, drugs)	Iron deficiency: ↓ferritin, ↑TIBC; ACD: ↑ferritin, ↓TIBC; Thal: normal/↑iron + target cells
Lung tumours	Adenocarcinoma (peripheral, TTF-1/Napsin-A), Squamous (central, keratin, p40+), Small cell (neuroendocrine, paraneoplastic)	Non-smokers & women → adenocarcinoma; small cell → early mets, chemo-responsive
Colorectal pathways	APC/β-catenin (adenoma–carcinoma), MSI (Lynch)	Right-sided: occult bleeding/anaemia; Left: obstruction “apple-core”
Breast lesions	DCIS (calcifications), LCIS (E-cadherin−), invasive ductal (desmoplastic), invasive lobular (single-file)	ER/PR/HER2 status predicts therapy; LCIS bilateral risk marker
Thyroid	Papillary (Orphan Annie, psammoma; RET/BRAF), Follicular (haematogenous), Medullary (C-cells; calcitonin; MEN2), Anaplastic (aggressive)	Radiation → papillary; FNA cytology key; follicular requires capsular/vascular invasion to diagnose
Liver patterns	Steatosis/steatohepatitis (ballooning, Mallory bodies), Viral hepatitis (piecemeal necrosis), Cirrhosis (bridging fibrosis, nodules)	Cholestasis: bile plugs; Autoimmune: interface hepatitis + plasma cells
Brain tumours	Glioblastoma (pseudopalisading), Oligodendroglioma (fried-egg, 1p/19q), Meningioma (whorls/psammoma), Medulloblastoma (children)	IDH mutation improves glioma prognosis; meningioma often dural-based

🧴 Special stains & IHC mapping

Infection: ZN (TB/Nocardia), GMS/PAS (fungi), Warthin–Starry (H. pylori), Gram (bacteria).
Tumour lineage: CK AE1/AE3 (carcinoma), p40/p63 (squamous), TTF-1/Napsin-A (lung adeno), CDX2 (colorectal), PSA (prostate), GATA3 (breast/urothelial), S100/SOX10 (melanoma), chromogranin/synaptophysin (neuroendocrine), CD45 (lymphoid).

📝 Quick self-quiz (hover to reveal answers)

Which necrosis type in pancreatitis around fat? Ans: Fat necrosis (saponification).
What three elements define Virchow’s triad? Ans: Endothelial injury, stasis/turbulence, hypercoagulability.
Caseating vs non-caseating granuloma - give a classic cause for each. Ans: TB (caseating); sarcoidosis (non-caseating).
Which tumour marker panel helps separate lung adeno vs squamous? Ans: TTF-1/Napsin-A (adeno) vs p40/p63 (squamous).
Red infarct organs? Ans: Lung, liver, intestine (dual supply/loose tissue) and reperfused areas.

🧭 Pathways & Checklists – From Sample to Sense

Clinical question	First steps	Pathology lens	Next tests
Solid organ mass	Imaging pattern (solid/cystic), labs (tumour markers where relevant)	Core biopsy preferred for architecture; avoid FNA alone when invasion/capsule matters (e.g., follicular thyroid)	IHC lineage panel; molecular drivers for therapy (EGFR/ALK/ROS1, BRAF, IDH, ER/PR/HER2)
Lymphadenopathy	Infective vs malignant features; B-symptoms; sites	Excisional biopsy best for architecture (reactive patterns vs lymphoma)	Flow cytometry (clonality), IHC (CD3/CD20), genetic (MYC/BCL2/BCL6)
Jaundice	Fractionate bilirubin; ALP/GGT vs ALT/AST	Cholestatic vs hepatocellular injury pattern; autoimmune vs viral vs toxic	Autoimmune panel (AMA, SMA, IgG4), viral serology, imaging for obstruction
Haematuria + proteinuria	BP, renal function, complements	Biopsy with LM/IF/EM triad; crescents imply RPGN	ANCA, anti-GBM, anti-PLA2R; infection history
Pulmonary opacity	Acute vs chronic; fever vs haemoptysis; smoking	Pattern recognition: consolidation (pneumonia), nodules (neoplasm), interstitial (ILD), cavitation (TB/abscess)	Sputum/bronchoscopy; biopsy for ILD pattern (UIP/NSIP) if needed

🧬 Cancer genetics – when to test

Predictive: EGFR/ALK/ROS1/RET (lung adeno), BRAF V600E (melanoma/thyroid/CRC subset), KRAS/NRAS (anti-EGFR resistance in CRC), HER2 (breast/upper GI), IDH1/2 & 1p/19q (glioma).
Hereditary: BRCA1/2 (breast/ovary/pancreas), MMR/MSI (Lynch), APC (FAP), VHL (RCC), MEN syndromes (RET, MEN1).

🧯 Sepsis – path to organ failure

Microbial products (LPS, lipoteichoic acid) & DAMPs trigger TLRs → cytokine storm (TNF/IL-1), NO-mediated vasodilation, endothelial leak, microthrombi (tissue factor/DIC), mitochondrial dysfunction → distributive shock and multi-organ failure.

🩺 Clinical Scenarios & Morphologic Clues

Young non-smoker with peripheral lung nodule: TTF-1+, mucin+, EGFR exon 19 deletion - targeted TKI candidate.
Microcytic anaemia, dysphagia, koilonychia: Iron deficiency; search GI blood loss; oesophageal web (Plummer–Vinson) ↑ SCC risk.
Nephrotic syndrome, spike & dome on silver stain: Membranous nephropathy (anti-PLA2R) ± secondary to malignancy/autoimmune/drugs.
Chronic cough, upper lobe cavitation, caseating granulomas: TB; AFB positive; risk of haemoptysis (Rasmussen aneurysm).
Painless haematuria in older smoker: Urothelial carcinoma (GATA3+); field cancerisation; look for CIS.
Post-MI day 3–7: Macrophage phase → wall softening → risk of free-wall rupture (tamponade) or papillary rupture (MR).
Child with abdominal mass, small round blue cells, t(11;22): Ewing sarcoma (EWSR1-FLI1), CD99 membranous.

🧠 Stroke pathology – timing table

Time	Changes
Minutes–hours	Red neurons (eosinophilic), oedema begins
1–3 days	Neutrophils → macrophages
3–14 days	Macrophages; liquefactive necrosis; reactive gliosis at edges
Weeks–months	Cystic cavity with gliotic wall

🧴 Barrett → adenocarcinoma sequence

Reflux → intestinal metaplasia (goblet cells) → dysplasia → intramucosal carcinoma → invasive adenocarcinoma. Risk ↑ with long-segment Barrett, male, obesity, smoking.

🧠 Study & Exam Tips

Pattern → Process → Prognosis: Name the morphologic pattern (e.g., granuloma), link to mechanism (Th1/IFN-γ), then state clinical consequence and next test.
Don’t mix grade and stage: Grade = how it looks; Stage = where it goes. Prognosis follows stage more than grade in most solid tumours.
Always anchor with a stain or marker: One special stain or IHC per vignette can clinch the diagnosis.
Time courses matter: Infarct histology, wound healing days, stroke timing - memorise the sequence.
Read slides “outside-in”: Low power for architecture → medium for pattern → high power for cells → then correlate with IHC/molecular.

🚀 Rapid drill (answers hidden)

Name a tumour that spreads haematogenously early despite being a carcinoma. Ans: Renal cell carcinoma (also HCC, follicular thyroid).
What activates macrophages in granulomas? Ans: IFN-γ from Th1 cells (driven by IL-12).
Which amyloid in chronic inflammatory states? Ans: AA amyloid (serum amyloid A).
Post-streptococcal GN: IF pattern? Ans: Granular (“lumpy-bumpy”) IgG/C3; subepithelial humps on EM.
Which thyroid carcinoma shows psammoma bodies and nuclear grooves? Ans: Papillary thyroid carcinoma.

Final thought: In every case, say what you see (pattern), why it’s there (mechanism), and what it means (prognosis/next step). Pathology becomes narrative, not memory. 💪

The content on this website is provided for educational and informational purposes only to support exam preparation (e.g., MLA, MRCP, USMLE) and learning. This is NOT medical advice, diagnosis, treatment, or professional guidance. It does not replace consultation with a qualified healthcare professional, official guidelines (e.g., NICE, GMC, BNF), or supervised clinical practice. Always verify information with current, authoritative sources. Makindo and its contributors accept no liability for any reliance on this content, including errors, omissions, or any resulting harm, loss, or consequences. By using this site, you agree to these terms.

Premed Pathology 🔬

🔢 Key Areas of Study

📏 Core Tables – Patterns, Stains & Differentials

🧭 Pathways & Checklists – From Sample to Sense

🩺 Clinical Scenarios & Morphologic Clues

🧠 Study & Exam Tips

Categories